UA31956A - METHOD OF EVALUATION OF EFFECTIVENESS OF TREATMENT OF PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS - Google Patents

METHOD OF EVALUATION OF EFFECTIVENESS OF TREATMENT OF PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS

Info

Publication number
UA31956A
UA31956A UA98116255A UA98116255A UA31956A UA 31956 A UA31956 A UA 31956A UA 98116255 A UA98116255 A UA 98116255A UA 98116255 A UA98116255 A UA 98116255A UA 31956 A UA31956 A UA 31956A
Authority
UA
Ukraine
Prior art keywords
treatment
psoriasis
effectiveness
psoriatic arthritis
patients
Prior art date
Application number
UA98116255A
Other languages
Ukrainian (uk)
Inventor
Всеволод Миколайович Романенко
Всеволод Николаевич Романенко
Едуард Федорович Баринов
Эдуард Федорович Баринов
Ігор Ваніфатієвич Свистунов
Игорь Ванифатиевич Свистунов
Марія Едуардівна Баринова
Мария Эдуардовна Баринова
Наталія Василівна Ковальчук
Наталья Васильевна Ковальчук
Тетяна Іванівна Шевченко
Татьяна Ивановна Шевченко
Надія Миколаївна Бондаренко
Надежда Николаевна Бондаренко
Оксана Миколаївна Ткачова
Оксана Николаевна Ткачева
Original Assignee
Донецький Державний Медичний Університет Ім. М. Горького
Донецкий Государственный Медицинский Университет Им. М. Горького
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Донецький Державний Медичний Університет Ім. М. Горького, Донецкий Государственный Медицинский Университет Им. М. Горького filed Critical Донецький Державний Медичний Університет Ім. М. Горького
Priority to UA98116255A priority Critical patent/UA31956A/en
Publication of UA31956A publication Critical patent/UA31956A/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Оцінку проводять шляхом дослідження клітин крові до і після лікування. Додатково інкубують еритроцити крові з О-адреностимулятором, після чого досліджують гіпотонічний гемоліз, і при зниженні його величини після проведеної терапії на 5-7% визначають ефективність лікування псоріазу і псоріатичного артриту.The assessment is performed by examining blood cells before and after treatment. Additionally, the erythrocytes of the blood are incubated with an O-adrenostimulant, after which hypotonic hemolysis is examined, and when its value is reduced after the therapy by 5-7%, the effectiveness of treatment of psoriasis and psoriatic arthritis is determined.

UA98116255A 1998-11-26 1998-11-26 METHOD OF EVALUATION OF EFFECTIVENESS OF TREATMENT OF PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS UA31956A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA98116255A UA31956A (en) 1998-11-26 1998-11-26 METHOD OF EVALUATION OF EFFECTIVENESS OF TREATMENT OF PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA98116255A UA31956A (en) 1998-11-26 1998-11-26 METHOD OF EVALUATION OF EFFECTIVENESS OF TREATMENT OF PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS

Publications (1)

Publication Number Publication Date
UA31956A true UA31956A (en) 2000-12-15

Family

ID=74283672

Family Applications (1)

Application Number Title Priority Date Filing Date
UA98116255A UA31956A (en) 1998-11-26 1998-11-26 METHOD OF EVALUATION OF EFFECTIVENESS OF TREATMENT OF PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS

Country Status (1)

Country Link
UA (1) UA31956A (en)

Similar Documents

Publication Publication Date Title
US4632980B1 (en)
DE19975031I2 (en) Use of 4-aminosalicyl acid as an anti-inflammatory agent.
EA200100721A1 (en) GABAPENTINA DERIVATIVE FOR THE PREVENTION AND TREATMENT OF VISCERAL PAIN
DE69921156D1 (en) USE OF 5HT-6 ANTAGONISTS FOR ADHD TREATMENT
PT1157041E (en) ANTIBODIES FOR CANCER THERAPY AND DIAGNOSIS
EA199900494A1 (en) DERIVATIVES 2- (PURIN-9-IL) -TETRAHYDROFURAN-3,4-DIOLA
BR9910251A (en) Hematopoietic stimulation
DE69721006D1 (en) USE OF THE OWN MODIFIED OWN BLOOD FOR THE TREATMENT OF AUTOIMMUNE DISEASES
ES2191192T3 (en) TIENOPIRIMIDINAS.
NO976063L (en) Procedure for the treatment of diabetes
HUP9800028A2 (en) Multiple-tumor aberrant growth genes
ATE258796T1 (en) USE OF VITAMIN D4 DERIVATIVES TO TREAT SKIN DISEASES
EA200401111A1 (en) TRANS-CAROTINOID BIPOLAR SALTS AND THEIR APPLICATION
NO971341D0 (en) Promoter for receptor tyrosine kinase TIE
ES2139957T3 (en) METHOD FOR THE DETERMINATION OF THE PRETHROMBOTIC STATE.
DE69228824T2 (en) DETECTION METHODS FOR C-Raf-1-GENES.5
EA199900138A1 (en) DETECTION OF MAMMALIAN HEPARANASE ACTIVITY AND MAMMALIAN HEPARANASE PURIFICATION
UA31956A (en) METHOD OF EVALUATION OF EFFECTIVENESS OF TREATMENT OF PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS
ES8704962A1 (en) 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamide for use in medical treatment of humans.
DE69129693D1 (en) USE OF NICKEL AND BROMIDE IONS FOR THE TREATMENT OF PSORIASIS
FI844645L (en) 1,7-DIPHENYL-3-METHYLAZA-7-CYAN-8-METHYL-NONAN FOR ANALYSIS OF THE CONSTRUCTION OF SJUKDOMAR.
BR9608147A (en) Method for microbial decontamination of blood platelets.
ATE40116T1 (en) 1-ACYL-3-PYRIDYLMETHYLGUANIDINE AND THEIR USE AS ANTIHYPERTENSIVES.
OA08298A (en) New N- (5-aminomethyl oxazolin-2 yl-2) N'-phenylureas, their method of preparation and their therapeutic application.
ATE260111T1 (en) AGENTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES